NWRN News

Latest breaking news and updates for NWRN stock.

Track all markets on TradingView

Newron Begins Enrollment in Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-Resistant Schizophrenia (TRS)

MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)---- $NWRN #schizophrenia--Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy for treatment-resistant schizop...

How does the sentiment score of 35 influence market expectations for this announcement? What are the regulatory implications if the trial demonstrates positive results for an FDA or EMA submission? How might this news affect the trading volume and liquidity of Newron’s stock (NWRN)?
Clinical trials
13 days ago
Read more businesswire

Newron Notes the Publication of New Preclinical Research Suggesting Evenamide Ameliorates Schizophrenia-Related Dysfunction

MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)---- $NWRN #schizophrenia--New findings in Neuropsychopharmacology - first to demonstrate that evenamide targets the key site of schizophrenia pathology in ...

How does the sentiment score of 65 influence investor perception compared to other recent clinical trial announcements in the sector? Will the company need to raise additional capital to fund clinical development of evenamide, and what impact could that have on dilution or financing terms? What are the risks if the preclinical results do not translate into clinical efficacy, and how should that be factored into risk assessments?
Clinical trials
14 days ago
Read more businesswire